NASHA hyaluronic acid for the treatment of shoulder osteoarthritis: a prospective, single-arm clinical trial.

ABSTRACT: Background: Osteoarthritis of the shoulder or glenohumeral joint is a painful condition that can be debilitating. Intra-articular injection with hyaluronic acid should be considered for patients not responding adequately to physical therapy or anti-inflammatory medication. Methods: This was a single-arm, open-label, prospective study of a single intra-articular injection of NASHA (non-animal hyaluronic acid) in patients with symptomatic glenohumeral osteoarthritis. Patients were followed up for 26 weeks post-treatment, during which time rescue medication with acetaminophen was permissible. The study objective was to demonstrate that a single injection of NASHA is well tolerated with an over-6-month 25% reduction in shoulder pain on movement, assessed using a 100-mm visual ana

SUBMITTER: McKee MD 

PROVIDER: S-EPMC6573776 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature